NeoGenomics
1 known investors
NeoGenomics provides oncology diagnostics and laboratory testing, offering over 500 tests across modalities including molecular testing, IHC, flow cytometry, FISH, next-generation sequencing, and comprehensive genomic profiling for solid tumors and hematologic cancers. It serves oncologists, patients, and biopharma partners in the US, supporting clinical care as well as drug development and clinical trials.
Investors · 1
Frequently asked questions
- What does NeoGenomics do?
- NeoGenomics provides oncology diagnostics and laboratory testing, offering over 500 tests across modalities including molecular testing, IHC, flow cytometry, FISH, next-generation sequencing, and comprehensive genomic profiling for solid tumors and hematologic cancers. It serves oncologists, patients, and biopharma partners in the US, supporting clinical care as well as drug development and clinical trials.
- Who are NeoGenomics's investors?
- NeoGenomics's investors include Ampersand.